Stanniocalcin

Last updated

Stanniocalcin (originally named hypocalcin or teleocalcin or parathyrin) [1] is a family of hormones which regulate calcium and phosphate balance in the body. The first stanniocalcin discovered was from fish and was identified as the principal calcium-reducing (hypocalcaemic) factor. [2] It was isolated from special organs in fish called corpuscles of Stannius, hence the name stanniocalcin. Chemically, stanniocalcins are glycosylated proteins (i.e. proteins containing carbohydrate, or glycoproteins) having a molecular mass of 50 kDa. They exist in molecular pairs (homodimers) and are joined together by disulfide linkage. Stanniocalcins are made up of approximately 250 amino acids. [3]

Contents

Discovery

In 1839, the German anatomist Hermann Friedrich Stannius discovered a pair of novel structures inside the kidneys of sturgeon and bony fishes. He believed that they were a kind of adrenal gland (found in mammals) in these fishes. In 1896, the French physiologist A. Petit demonstrated that removal of one of the structures led to degeneration of the other. He suggested that these structures were endocrine organs. In 1908, the Italian zoologist Ercole Giacomini was the first to describe that these structures were present only in fishes which lack a parathyroid gland. He distinguished and named them "posterior interrenal" from the anterior portion of the kidney, which he named "anterior interrenal". [4] A French Physiologist M. Fontaine reported that the corpuscles were responsible for controlling calcium level in the blood. In 1971 Peter K.T. Pang of Yale University showed in the male killifish, Fundulus heteroclitus, that the corpuscles control calcium metabolism. He found that removal of the corpuscle led to development of kidney stone and increase in serum calcium level. [5] By the mid 1970s, it was confirmed that the corpuscles secrete a factor that can reduce calcium level, similar to calcitonin but completely different. and Pang gave the prospective name "hypocalcin". [6] [7] The chemical compound was isolated in 1986 from sockeye salmon (Oncorhynchus nerka), and since it was from a teleost, it was called "teleocalcin". [2] [8] A better isolation was reported in 1988 from different species, including European eel, tilapia, goldfish, and carp. It was realised that both hypocalcin and teleocalcin are the same. [3] It was conclusively shown that the isolated compound was the factor that reduces calcium level in these fishes. [9] [10] In 1990, the exact chemical composition and biosynthesis war worked out, and was given the name "stanniocalcin" as it was found to be exclusively produced by the corpuscles of Stannius. [11] The complete amino acid sequence was described in 1995. [12]

Structure

Stanniocalcin is a glycoprotein that exists in a homodimer, i.e. two similar peptide molecules combined. Each single molecule is made up of 179 amino acids. The peptide sequence is characterised by the presence of 11 half-Cys residues and one N-linked glycosylation site. [12] The actual amino acid sequence and total length differ between species, hence, the molecular weight. In most species it is 54 kDa in size. [3] While it is only 44 kDa in Atlantic salmon. [13] In chum salmon, the homodimer in joined by a single intermonomeric disulfide bond at Cys169. Each monomer in turn contains five intramonomeric disulfide bonds formed between Cys12-Cys26, Cys21-Cys41, Cys32-Cys81, Cys65-Cys95, and Cys102-Cys137. [14] Its synthesis is regulated by the expression of STC (stannioclacin) mRNA. The STC mRNA sequence varies from species to species. For example, in salmon it is approximately 2 kilobases in length and encodes a primary translation product of 256 amino acids. The first 33 residues comprise the pre-pro (inactive form) region of the hormone, whereas the remaining 223 residues make up the mature form of the hormone. One N-linked, glycosylation consensus sequence was identified in the protein coding region as well as an odd number of half cysteine residues, the latter of which would allow for interchain bonding or dimerisation of monomeric subunits. [15]

Function

In bony fishes, stanniocalcin is the principal hormone that regulate calcium level. Even though other calcium-decreasing hormone, calcitonin, is also present, these fishes require more efficient hormone as calcium rapidly enters into their blood through their gills and intestinal wall. Hence, the target sites of stanniocalsin are gill and intestine, where uptake (absorption) of calcium is directly inhibited. [16] Increase in the serum calcium triggers the release of stanniocalcin. Unlike calcitonin, it also regulates phosphate level. [17] It inhibits excretion of phosphate from the kidney. [1]

Variation in other animals

Stanniocalcin was also detected in mammals. In mammals there are two variant forms, STC1, which is fundamentally similar to fish stanniocalcin, and STC2, which is more different in structure and function. In invertebrates, freshwater leeches are found to contain the hormone. In leeches it is produced in the fat cells (adipocytes). [18]

STC1

STC1 was discovered in 1995 from human kidney. It was demonstrated that human kidney extract produced the same calcium inhibitory action when injected in a fish. [19] The gene that produce STC1, STC1 is located in the short arm of human chromosome 8 (position p21.2). STC1 mRNA is formed in heart, lung, liver, adrenal gland, prostate, and ovary, indicating that these are the sites of synthesis. Ovary contains the highest level of STC1 mRNA. Fish stanniocalcin and mammalian STC1 are closely related, and are about 50% similar in their structure. [20] They are both responsible for calcium and phosphate balance. [21] In mammals the predominant function of STC1 is to activate phosphate reabsorption in the small intestine and proximal tubules of the kidney. [22]

STC2

STC2 was discovered from the human DNA database. [23] In human STC2 is produced by STC2 gene which is located in the long arm of human chromosome 5 (position q35.1). It is very different from STC1 and show only 34% similarity. STC2 mRNA is found in pancreas, kidney, spleen, and skeletal muscles. [20]

Medical importance

Mammalian stanniocalcins are known to be related to cancer development, such as breast and ovarian cancers. In these cancers, both STC1 and STC2 are excessively produced. Their location in chromosomes are the sites of genes for tumour formation. [22] In breast cancer the elevated hormones correspond to increased estrogen receptors. Increased STC1 is specifically linked to other cancer types, including leukemia, colorectal cancer, carcinoma, and lung cancer. [24] STC2 is related to cervical cancer, [25] and ovarian cancer. [26]

Related Research Articles

<span class="mw-page-title-main">Methionine</span> Sulfur-containing amino acid

Methionine is an essential amino acid in humans. As the precursor of other amino acids such as cysteine and taurine, versatile compounds such as SAM-e, and the important antioxidant glutathione, methionine plays a critical role in the metabolism and health of many species, including humans. It is encoded by the codon AUG.

<span class="mw-page-title-main">Nephron</span> Microscopic structural and functional unit of the kidney.

The nephron is the minute or microscopic structural and functional unit of the kidney. It is composed of a renal corpuscle and a renal tubule. The renal corpuscle consists of a tuft of capillaries called a glomerulus and a cup-shaped structure called Bowman's capsule. The renal tubule extends from the capsule. The capsule and tubule are connected and are composed of epithelial cells with a lumen. A healthy adult has 1 to 1.5 million nephrons in each kidney. Blood is filtered as it passes through three layers: the endothelial cells of the capillary wall, its basement membrane, and between the foot processes of the podocytes of the lining of the capsule. The tubule has adjacent peritubular capillaries that run between the descending and ascending portions of the tubule. As the fluid from the capsule flows down into the tubule, it is processed by the epithelial cells lining the tubule: water is reabsorbed and substances are exchanged ; first with the interstitial fluid outside the tubules, and then into the plasma in the adjacent peritubular capillaries through the endothelial cells lining that capillary. This process regulates the volume of body fluid as well as levels of many body substances. At the end of the tubule, the remaining fluid—urine—exits: it is composed of water, metabolic waste, and toxins.

<span class="mw-page-title-main">Cortisol</span> Human natural glucocorticoid hormone

Cortisol is a steroid hormone, in the glucocorticoid class of hormones. When used as a medication, it is known as hydrocortisone.

<span class="mw-page-title-main">Parathyroid hormone</span> Mammalian protein found in Homo sapiens

Parathyroid hormone (PTH), also called parathormone or parathyrin, is a peptide hormone secreted by the parathyroid glands that regulates the serum calcium concentration through its effects on bone, kidney, and intestine.

<span class="mw-page-title-main">Calcium metabolism</span> Movement and regulation of calcium ions in and out of the body

Calcium metabolism is the movement and regulation of calcium ions (Ca2+) in (via the gut) and out (via the gut and kidneys) of the body, and between body compartments: the blood plasma, the extracellular and intracellular fluids, and bone. Bone acts as a calcium storage center for deposits and withdrawals as needed by the blood via continual bone remodeling.

<span class="mw-page-title-main">Calcitonin</span> Amino acid peptide hormone secreted by the thyroid gland

Calcitonin is a 32 amino acid peptide hormone secreted by parafollicular cells (also known as C cells) of the thyroid (or endostyle) in humans and other chordates in the ultimopharyngeal body. It acts to reduce blood calcium (Ca2+), opposing the effects of parathyroid hormone (PTH).

<span class="mw-page-title-main">Hyperparathyroidism</span> Increase in parathyroid hormone levels in the blood

Hyperparathyroidism is an increase in parathyroid hormone (PTH) levels in the blood. This occurs from a disorder either within the parathyroid glands or as response to external stimuli. Symptoms of hyperparathyroidism are caused by inappropriately normal or elevated blood calcium leaving the bones and flowing into the blood stream in response to increased production of parathyroid hormone. In healthy people, when blood calcium levels are high, parathyroid hormone levels should be low. With long-standing hyperparathyroidism, the most common symptom is kidney stones. Other symptoms may include bone pain, weakness, depression, confusion, and increased urination. Both primary and secondary may result in osteoporosis.

<span class="mw-page-title-main">Calcitriol</span> Active form of vitamin D

Calcitriol is the active form of vitamin D, normally made in the kidney. It is also known as 1,25-dihydroxycholecalciferol. It is a hormone which binds to and activates the vitamin D receptor in the nucleus of the cell, which then increases the expression of many genes. Calcitriol increases blood calcium (Ca2+) mainly by increasing the uptake of calcium from the intestines.

<span class="mw-page-title-main">Klotho (biology)</span> Human enzyme

Klotho is an enzyme that in humans is encoded by the KL gene. The three subfamilies of klotho are α-klotho, β-klotho, and γ-klotho. α-klotho activates FGF23, and β-klotho activates FGF19 and FGF21. When the subfamily is not specified, the word "klotho" typically refers to the α-klotho subfamily, because α-klotho was discovered before the other members.

<span class="mw-page-title-main">Secondary hyperparathyroidism</span> Medical condition

Secondary hyperparathyroidism is the medical condition of excessive secretion of parathyroid hormone (PTH) by the parathyroid glands in response to hypocalcemia, with resultant hyperplasia of these glands. This disorder is primarily seen in patients with chronic kidney failure. It is sometimes abbreviated "SHPT" in medical literature.

<span class="mw-page-title-main">Tertiary hyperparathyroidism</span> Medical condition

Tertiary hyperparathyroidism is a condition involving the overproduction of the hormone, parathyroid hormone, produced by the parathyroid glands. The parathyroid glands are involved in monitoring and regulating blood calcium levels and respond by either producing or ceasing to produce parathyroid hormone. Anatomically, these glands are located in the neck, para-lateral to the thyroid gland, which does not have any influence in the production of parathyroid hormone. Parathyroid hormone is released by the parathyroid glands in response to low blood calcium circulation. Persistent low levels of circulating calcium are thought to be the catalyst in the progressive development of adenoma, in the parathyroid glands resulting in primary hyperparathyroidism. While primary hyperparathyroidism is the most common form of this condition, secondary and tertiary are thought to result due to chronic kidney disease (CKD). Estimates of CKD prevalence in the global community range from 11 to 13% which translate to a large portion of the global population at risk of developing tertiary hyperparathyroidism. Tertiary hyperparathyroidism was first described in the late 1960s and had been misdiagnosed as primary prior to this. Unlike primary hyperparathyroidism, the tertiary form presents as a progressive stage of resolved secondary hyperparathyroidism with biochemical hallmarks that include elevated calcium ion levels in the blood, hypercalcemia, along with autonomous production of parathyroid hormone and adenoma in all four parathyroid glands. Upon diagnosis treatment of tertiary hyperparathyroidism usually leads to a surgical intervention.

<span class="mw-page-title-main">TRPV6</span> Protein-coding gene in the species Homo sapiens

TRPV6 is a membrane calcium (Ca2+) channel protein which is particularly involved in the first step in Ca2+absorption in the intestine.

<span class="mw-page-title-main">Fibroblast growth factor 23</span> Protein-coding gene in the species Homo sapiens

Fibroblast growth factor 23 (FGF23) is a protein and member of the fibroblast growth factor (FGF) family which participates in the regulation of phosphate in plasma and vitamin D metabolism. In humans it is encoded by the FGF23 gene. FGF23 decreases reabsorption of phosphate in the kidney. Mutations in FGF23 can lead to its increased activity, resulting in autosomal dominant hypophosphatemic rickets.

<span class="mw-page-title-main">Calcium-sensing receptor</span> Mammalian protein found in Homo sapiens

The calcium-sensing receptor (CaSR) is a Class C G-protein coupled receptor which senses extracellular levels of calcium ions. It is primarily expressed in the parathyroid gland, the renal tubules of the kidney and the brain. In the parathyroid gland, it controls calcium homeostasis by regulating the release of parathyroid hormone (PTH). In the kidney it has an inhibitory effect on the reabsorption of calcium, potassium, sodium, and water depending on which segment of the tubule is being activated.

<span class="mw-page-title-main">STC1</span> Glycoprotein, a homologue of a hormone stanniocalcin

Stanniocalcin-1 is a glycoprotein, a homologue of a hormone stanniocalcin, first discovered in bony fishes. In humans it is encoded by the STC1 gene.

<span class="mw-page-title-main">STC2</span> Protein-coding gene in the species Homo sapiens

Stanniocalcin-2 is a protein that in humans is encoded by the STC2 gene.

<span class="mw-page-title-main">Teleost leptins</span>

Teleost leptins are a family of peptide hormones found in fish (teleostei) that are orthologs of the mammalian hormone leptin. The teleost and mammalian leptins appear to have similar functions, namely, regulation of energy intake and expenditure.

The parathyroid hormone family is a family of structurally and functionally related proteins. Parathyroid hormone (PTH) is a polypeptidic hormone primarily involved in calcium metabolism. The parathyroid hormone-related protein (PTH-rP) is a related protein with predominantly paracrine function and possibly an endocrine role in lactation, as PTHrP has been found to be secreted by mammary glands into the circulation and increase bone turnover. PTH and PTH-rP bind to the same G-protein coupled receptor. The related protein PTH-L has been found in teleost fish, which also have two forms of PTH and PTHrP. Three subfamilies can be identified: PTH, PTHrP and PTH-L.

<span class="mw-page-title-main">Corpuscle of Stannius</span> Special endocrine organs in the kidney in fish

The corpuscles of Stannius are special endocrine organs in the kidney in fish and are responsible for maintaining calcium balance. They are found only in bony fishes. They were discovered and described by a German anatomist Hermann Friedrich Stannius in 1839. Stannius considered them as functionally similar to adrenal glands in mammals. But they have later been found to be anatomically different as they are derived from different tissues of the embryo. Structurally the corpuscles are a large number of spherical bodies separated from each other by loose connective tissues. Each body or lobule is in turn composed of several columnar cells, which contain secretory granules and are, thus, secretory in function. Each Secretory granule is spherical in shape and measures 0.5 to 1 μm in diameter. Their possible endocrine nature, i.e. producing hormone, was suspected from the complete anatomical description, and it was believed to be responsible for regulating calcium level in the blood. The hormone was identified as stanniocalcin.

<span class="mw-page-title-main">Phenypressin</span> Chemical compound

Phenypressin (Phe2-Arg8-vasopressin) is an oxytocin neuropeptide belonging to the vertebrae vasopressin family and has similar pharmacological properties as arginine vasopressin. The name phenypressin came about because there is a substitution of phenylalanine that makes it different from arginine vasopressin in the second residue and that is the only difference. It belongs to the family, neurohypophysial hormones, named after the fact that they are secreted by the neurohypophysis which is a neural projection from the hypothalamus. It has mostly been found to be present is some species belonging to the family, Macropodidae, particularly eastern gray kangaroos[3], red kangaroos, tammar wallaby, and the quokka wallaby. In other marsupial families, Phenypressin has not yet specifically been identified, but they do have other vasopressin-like peptides present.

References

  1. 1 2 Suzuki, Nobuo (2015). "Stanniocalcin". In Takei, Yoshio; Ando, Hironori; Tsutsui, Kazuyoshi (eds.). Handbook of Hormones: Comparative Endocrinology for Basic and Clinical Research. Oxford (UK): Academic Press. pp. 247–249. ISBN   978-0-12-801067-9.
  2. 1 2 Wagner, GF; Hampong, M; Park, CM; Copp, DH (1986). "Purification, characterization, and bioassay of teleocalcin, a glycoprotein from salmon corpuscles of Stannius". General and Comparative Endocrinology. 63 (3): 481–91. doi:10.1016/0016-6480(86)90149-8. PMID   3557071.
  3. 1 2 3 Lafeber, FP; Hanssen, RG; Choy, YM; Flik, G; Herrmann-Erlee, MP; Pang, PK; Bonga, SE (1988). "Identification of hypocalcin (teleocalcin) isolated from trout Stannius corpuscles" (PDF). General and Comparative Endocrinology. 69 (1): 19–30. doi:10.1016/0016-6480(88)90048-2. hdl: 2066/16625 . PMID   3360288.
  4. ↑ Nadkarni, V. B.; Gorbman, Aubrey (1966). "Structure of the corpuscle of Stannius in normal and radiothyroidectomized chinook fingerlings and spawning Pacific salmon". Acta Zoologica. 47 (1–2): 61–66. doi:10.1111/j.1463-6395.1966.tb00741.x.
  5. ↑ Pang, Peter K. T. (1971). "The relationship between corpuscles of Stannius and serum electrolyte regulation in killifish, Fundulus heteroclitus". Journal of Experimental Zoology. 178 (1): 1–8. doi:10.1002/jez.1401780102. PMID   5094234.
  6. ↑ Pang, PK; Pang, RK (1974). "Environmental calcium and hypocalcin activity in the Stannius corpuscles of the channel catfish, Ictalurus punctatus (Rafinesque)". General and Comparative Endocrinology. 23 (2): 239–241. doi:10.1016/0016-6480(74)90133-6. PMID   4837805.
  7. ↑ Olivereau, M; Olivereau, J (1978). "Prolactin, hypercalcemia and corpuscles of Stannius in seawater eels". Cell and Tissue Research. 186 (1): 81–96. doi:10.1007/bf00219656. PMID   627014. S2CID   24457863.
  8. ↑ Wagner, Graham F.; Friesen, Henry G. (1989). "Studies on the structure and physiology of salmon teleocalcin". Fish Physiology and Biochemistry. 7 (1–6): 367–374. doi:10.1007/BF00004730. PMID   24221795. S2CID   22823404.
  9. ↑ Lafeber, FP; Flik, G; Wendelaar Bonga, SE; Perry, SF (1988). "Hypocalcin from Stannius corpuscles inhibits gill calcium uptake in trout". The American Journal of Physiology. 254 (6 Pt 2): R891-6. doi:10.1152/ajpregu.1988.254.6.R891. hdl: 2066/16626 . PMID   3381914.
  10. ↑ Lafeber, FP; Perry, SF (1988). "Experimental hypercalcemia induces hypocalcin release and inhibits branchial Ca2+ influx in freshwater trout". General and Comparative Endocrinology. 72 (1): 136–143. doi:10.1016/0016-6480(88)90189-x. PMID   3181737.
  11. ↑ Flik, G; Labedz, T; Neelissen, JA; Hanssen, RG; Wendelaar Bonga, SE; Pang, PK (1990). "Rainbow trout corpuscles of Stannius: stanniocalcin synthesis in vitro". The American Journal of Physiology. 258 (5 Pt 2): R1157-1164. doi:10.1152/ajpregu.1990.258.5.R1157. PMID   2337196.
  12. 1 2 Yamashita, Kunihiko; Koide, Yoshio; Itoh, Hiromichi; Kawada, Naoki; Kawauchi, Hiroshi (1995). "The complete amino acid sequence of chum salmon stanniocalcin, a calcium-regulating hormone in teleosts". Molecular and Cellular Endocrinology. 112 (2): 159–167. doi:10.1016/0303-7207(95)03590-4. PMID   7489819. S2CID   39537422.
  13. ↑ Wagner, GF; Jaworski, EM; Haddad, M (1998). "Stanniocalcin in the seawater salmon: structure, function, and regulation". The American Journal of Physiology. 274 (4 Pt 2): R1177-1185. doi: 10.1152/ajpregu.1998.274.4.R1177 . PMID   9575986.
  14. ↑ Hulova, Irena; Kawauchi, Hiroshi (1999). "Assignment of disulfide linkages in chum salmon stanniocalcin". Biochemical and Biophysical Research Communications. 257 (2): 295–299. doi:10.1006/bbrc.1999.0466. PMID   10198206.
  15. ↑ Wagner, Graham F.; Dimattia, Gabriel E.; Davie, James R.; Copp, D.Harold; Friesen, Henry G. (1992). "Molecular cloning and cDNA sequence analysis of coho salmon stanniocalcin". Molecular and Cellular Endocrinology. 90 (1): 7–15. doi:10.1016/0303-7207(92)90095-N. PMID   1363790. S2CID   46389908.
  16. ↑ Flik, G (1990). "Hypocalcin physiology". Progress in Clinical and Biological Research. 342: 578–585. PMID   2200039.
  17. ↑ Wagner, GF; Jaworski, EM; Haddad, M (1998). "Stanniocalcin in the seawater salmon: structure, function, and regulation". The American Journal of Physiology. 274 (4 Pt 2): R1177-1185. doi: 10.1152/ajpregu.1998.274.4.R1177 . PMID   9575986.
  18. ↑ Tanega, Cherry; Radman, Dennis P.; Flowers, Bree; Sterba, Thomas; Wagner, Graham F. (2004). "Evidence for stanniocalcin and a related receptor in annelids". Peptides. 25 (10): 1671–1679. doi:10.1016/j.peptides.2004.02.024. PMID   15476934. S2CID   22476519.
  19. ↑ Wagner, GF; Guiraudon, CC; Milliken, C; Copp, DH (1995). "Immunological and biological evidence for a stanniocalcin-like hormone in human kidney". Proceedings of the National Academy of Sciences of the United States of America. 92 (6): 1871–1875. doi: 10.1073/pnas.92.6.1871 . PMC   42384 . PMID   7892193.
  20. 1 2 Ishibashi, Kenichi; Imai, Masashi (2002). "Prospect of a stanniocalcin endocrine/paracrine system in mammals". American Journal of Physiology. 282 (3): F367–F375. doi:10.1152/ajprenal.00364.2000. PMID   11832417.
  21. ↑ Madsen, KL; Tavernini, MM; Yachimec, C; Mendrick, DL; Alfonso, PJ; Buergin, M; Olsen, HS; Antonaccio, MJ; Thomson, AB; Fedorak, RN (1998). "Stanniocalcin: a novel protein regulating calcium and phosphate transport across mammalian intestine". The American Journal of Physiology. 274 (1 Pt 1): G96-102. doi:10.1152/ajpgi.1998.274.1.G96. PMID   9458778.
  22. 1 2 Yeung, B.H.Y.; Law, A.Y.S.; Wong, Chris K.C. (2012). "Evolution and roles of stanniocalcin". Molecular and Cellular Endocrinology. 349 (2): 272–280. doi:10.1016/j.mce.2011.11.007. PMID   22115958. S2CID   10848821.
  23. ↑ Wagner, Graham F.; Dimattia, Gabriel E. (2006). "The stanniocalcin family of proteins". Journal of Experimental Zoology Part A: Comparative Experimental Biology. 305A (9): 769–780. doi:10.1002/jez.a.313. PMID   16902962.
  24. ↑ Chu, S.-J.; Zhang, J.; Zhang, R.; Lu, W.-W.; Zhu, J.-S. (2015). "Evolution and functions of stanniocalcins in cancer". International Journal of Immunopathology and Pharmacology. 28 (1): 14–20. doi: 10.1177/0394632015572745 . PMID   25816401. S2CID   11212156.
  25. ↑ Wang, Yuxia; Gao, Ying; Cheng, Hairong; Yang, Guichun; Tan, Wenhua (2015). "Stanniocalcin 2 promotes cell proliferation and cisplatin resistance in cervical cancer". Biochemical and Biophysical Research Communications. 466 (3): 362–368. doi:10.1016/j.bbrc.2015.09.029. PMID   26361149.
  26. ↑ Wu, Jingjing; Lai, Maode; Shao, Changshun; Wang, Jian; Wei, Jian-Jun (2015). "STC2 overexpression mediated by HMGA2 is a biomarker for aggressiveness of high-grade serous ovarian cancer". Oncology Reports. 34 (3): 1494–502. doi: 10.3892/or.2015.4120 . PMC   6918813 . PMID   26165228.
This page is based on this Wikipedia article
Text is available under the CC BY-SA 4.0 license; additional terms may apply.
Images, videos and audio are available under their respective licenses.